The C-Scan System has received CE marking for marketing in Europe and approval from the Israeli Ministry of Health, the Medical Device Division (AMAR) for marketing in Israel
Check-Cap has received approval from the Israeli Ministry of Health, the Medical Device Division (known as AMAR), to initiate commercial sales in Israel of the C-Scan system that received CE Mark approval in January 2018.
The objective of the study is to assess safety and clinical performance of the C-Scan system Version 3 in detecting patients with polyps. In a recent multi-center study on 31 evaluable patients, the C-Scan system Version 3, equipped with improved algorith